Figures present challenge to policymakers who have pushed to speed up budget spending to overcome weaker growth ...
Summits in China and the Philippines provide a backdrop for a string of meetings involving powerful global rivals ...
Prime minister will tell a City of London audience that he is prepared for a national discussion about a longer-term accord with Europe ...
Johnson & Johnson is poised to buy a privately held eye disease drug developer for up to $3.4bn, the latest in a glut of bolt-on acquisitions in the biotechnology sector. The New Jersey-based ...
Also in today’s newsletter: data centre construction stocks lose $4.2tn and the FDA rejects a cancer drug invented in China ...
Tech supporters lobby chipmaker’s board to reinstate former CEO after he resigned following affair with alleged Chinese spy ...
Estonia will close its border with Russia in December after blaming Moscow for a second alleged sabotage attempt on a defence company in the Baltic state.
Pact comes ahead of Donald Trump’s meeting with Xi Jinping at the Asia-Pacific Economic Cooperation forum in Shenzhen ...
US Treasury secretary Scott Bessent has called on Nvidia to find its new chief executive outside the company, saying the embattled chip giant needs a “dramatic shake-up”.
Beijing owns freehold to about 100 flats near the Tower of London, provoking fears of surveillance, nuisance and leasehold problems ...
The US drug regulator has rejected a cancer medicine developed by an American biotech company that was invented in China, raising questions about how the booming Chinese biotech sector can broaden its ...
Electricity bills for businesses are set to rise by about 13 per cent on average by the end of the decade, according to new forecasts that illustrate the challenges facing the UK government as it ...